Provexis (CHIX:PXSL) Quick Ratio: 3.45 (As of Sep. 2025) — 19% Above Median


What is Provexis Quick Ratio?

Provexis CHIX:PXSL Quick Ratio is 3.45 as of Sep. 2025, which is 19% above its 10-year median of 2.91. The stock has 1 warning sign investors should review. Among 994 Drug Manufacturers companies, Provexis ranks better than 80.08% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Provexis's quick ratio for the quarter that ended in Sep. 2025 was 3.45.

Provexis has a quick ratio of 3.45. It generally indicates good short-term financial strength.

The historical rank and industry rank for Provexis's Quick Ratio or its related term are showing as below:

CHIX:PXSl' s Quick Ratio Range Over the Past 10 Years
Min: 0.95   Med: 2.91   Max: 8.16
Current: 3.45

During the past 13 years, Provexis's highest Quick Ratio was 8.16. The lowest was 0.95. And the median was 2.91.

CHIX:PXSl's Quick Ratio is ranked better than
80.08% of 994 companies
in the Drug Manufacturers industry
Industry Median: 1.45 vs CHIX:PXSl: 3.45

Provexis  (CHIX:PXSl) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Provexis Quick Ratio Related Terms


Provexis Quick Ratio Historical Data

* Premium members only.

The historical data trend for Provexis's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provexis Quick Ratio Chart

Provexis Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.16 6.59 2.76 1.18 3.27

Provexis Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.96 1.18 1.42 3.27 3.45

CHIX:PXSL vs ZTS, UTHR, VTRS: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Provexis Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Provexis's Quick Ratio falls into.



Provexis Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Provexis's Quick Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Quick Ratio (A: Mar. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.012-0.202)/0.248
=3.27

Provexis's Quick Ratio for the quarter that ended in Sep. 2025 is calculated as

Quick Ratio (Q: Sep. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.842-0.044)/0.231
=3.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 3.45 mean?
Provexis (CHIX:PXSL) has a Quick Ratio of 3.45 as of Sep. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Provexis and its competitors. This is 19% above median its historical median of 2.91. Over the past decade, Provexis' Quick Ratio has ranged from 0.95 to 8.16. According to the industry distribution chart, Provexis ranks #198 out of 994 companies in the Drug Manufacturers industry, placing it in the top 19.9%.
Is Provexis' Quick Ratio too high?
Provexis' current Quick Ratio of 3.45 is 19% above median its 10-year median of 2.91. Over the past 10 years, this metric has ranged from a low of 0.95 to a high of 8.16. The Drug Manufacturers industry median Quick Ratio is 1.45. Provexis' value of 3.45 is 137.9% above this industry median. Based on the distribution chart, Provexis ranks #198 out of 994 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Provexis' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Provexis ranks #198 out of 994 companies for Quick Ratio. This places Provexis in the top 20% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Provexis' value of 3.45 is 137.9% above this benchmark. Historically, Provexis' own Quick Ratio has ranged from 0.95 to 8.16 over the past decade. While the company's 10-year median is 2.91 vs. the industry median of 1.45, Provexis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Provexis's current Quick Ratio of 3.45 is 137.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Provexis and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Provexis's current Quick Ratio is 3.45, which is 19% above median its own 10-year median of 2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Provexis stock overvalued right now?
Provexis (CHIX:PXSL) has a current Quick Ratio of 3.45. The current Quick Ratio is 3.45, which is 19% above median its 10-year median of 2.91 and 137.9% above the Drug Manufacturers industry median of 1.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Provexis (CHIX:PXSL), the current Quick Ratio is 3.45 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Provexis Business Description

Other Exchanges PXS:UKNZCA:Germany
Address 2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.